keyword
https://read.qxmd.com/read/34500703/qsar-based-computational-approaches-to-accelerate-the-discovery-of-sigma-2-receptor-s2r-ligands-as-therapeutic-drugs
#21
JOURNAL ARTICLE
Yangxi Yu, Hiep Dong, Youyi Peng, William J Welsh
S2R overexpression is associated with various forms of cancer as well as both neuropsychiatric disorders (e.g., schizophrenia) and neurodegenerative diseases (Alzheimer's disease: AD). In the present study, three ligand-based methods (QSAR modeling, pharmacophore mapping, and shape-based screening) were implemented to select putative S2R ligands from the DrugBank library comprising 2000+ entries. Four separate optimization algorithms (i.e., stepwise regression, Lasso, genetic algorithm (GA), and a customized extension of GA called GreedGene) were adapted to select descriptors for the QSAR models...
August 30, 2021: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/34414219/antidepressant-drugs-effects-on-blood-pressure
#22
REVIEW
Anna Calvi, Ilaria Fischetti, Ignazio Verzicco, Martino Belvederi Murri, Stamatula Zanetidou, Riccardo Volpi, Pietro Coghi, Stefano Tedeschi, Mario Amore, Aderville Cabassi
Individuals suffering from depressive disorders display a greater incidence of hypertension compared with the general population, despite reports of the association between depression and hypotension. This phenomenon may depend, at least in part, on the use of antidepressant drugs, which may influence blood pressure through different effects on adrenergic and serotoninergic pathways, as well as on histaminergic, dopaminergic, and cholinergic systems. This review summarizes extant literature on the effect of antidepressant drugs on blood pressure...
2021: Frontiers in Cardiovascular Medicine
https://read.qxmd.com/read/34318795/a-3d-cell-printing-fabricated-hepg2-liver-spheroid-model-for-high-content-in-situ-quantification-of-drug-induced-liver-toxicity
#23
JOURNAL ARTICLE
Sera Hong, Joon Myong Song
3D spheroid cultures are attractive candidates for application in in vitro drug-induced hepatotoxicity testing models to improve the reliability of biological information obtainable from a simple 2D culture model. Various 3D spheroid culture models exist for hepatotoxicity screening, but quantitative assays of spheroid response in situ are still challenging to achieve with the current 3D liver toxicity platforms. In this study, we developed a 3D printing-based HepG2 liver spheroid culture model for in situ quantitative evaluation and high-content monitoring of drug-induced hepatotoxicity...
July 27, 2021: Biomaterials Science
https://read.qxmd.com/read/34034811/beneficial-and-harmful-effects-of-antidepressants-versus-placebo-active-placebo-or-no-intervention-for-adults-with-major-depressive-disorder-a-protocol-for-a-systematic-review-of-published-and-unpublished-data-with-meta-analyses-and-trial-sequential-analyses
#24
JOURNAL ARTICLE
Sophie Juul, Faiza Siddiqui, Marija Barbateskovic, Caroline Kamp Jørgensen, Michael Pascal Hengartner, Irving Kirsch, Christian Gluud, Janus Christian Jakobsen
BACKGROUND: Major depressive disorder is one of the most common, burdensome, and costly psychiatric disorders worldwide. Antidepressants are frequently used to treat major depressive disorder. It has been shown repeatedly that antidepressants seem to reduce depressive symptoms with a statistically significant effect, but the clinical importance of the effect sizes seems questionable. Both beneficial and harmful effects of antidepressants have not previously been sufficiently assessed...
May 25, 2021: Systematic Reviews
https://read.qxmd.com/read/33819548/testing-in-vitro-tools-for-the-prediction-of-cholestatic-liver-injury-induced-by-non-pharmaceutical-chemicals
#25
JOURNAL ARTICLE
Eva Gijbels, Lindsey Devisscher, Mathieu Vinken
Bile acid accumulation and subsequent liver damage is a frequent adverse effect induced by drugs. Considerable efforts have therefore been focused on the introduction and characterization of tools that allow reliable prediction of this type of drug-induced liver injury. Among those are the cholestatic index and transcriptomic profiling, which are typically assessed in in vitro settings. The present study was set up to test the applicability of both tools to non-pharmaceutical compounds with cholestatic potential, including the industrial compound bis(2-ethylhexyl)phthalate, the cosmetic ingredients triclosan and octynoic acid, the herbicides paraquat and quizalofop-para-ethyl, and the food additives sunset yellow and tartrazine, in a human hepatoma cell culture model of cholestatic liver injury...
June 2021: Food and Chemical Toxicology
https://read.qxmd.com/read/33673822/conditional-power-of-antidepressant-network-meta-analysis
#26
JOURNAL ARTICLE
Lisa Holper
BACKGROUND: Conditional power of network meta-analysis (NMA) can support the planning of randomized controlled trials (RCTs) assessing medical interventions. Conditional power is the probability that updating existing inconclusive evidence in NMA with additional trial(s) will result in conclusive evidence, given assumptions regarding trial design, anticipated effect sizes, or event probabilities. METHODS: The present work aimed to estimate conditional power for potential future trials on antidepressant treatments...
March 5, 2021: BMC Psychiatry
https://read.qxmd.com/read/33661528/second-generation-antidepressants-for-treatment-of-seasonal-affective-disorder
#27
JOURNAL ARTICLE
Barbara Nussbaumer-Streit, Kylie Thaler, Andrea Chapman, Thomas Probst, Dietmar Winkler, Andreas Sönnichsen, Bradley N Gaynes, Gerald Gartlehner
BACKGROUND: Seasonal affective disorder (SAD) is a seasonal pattern of recurrent depressive episodes that is often treated with second-generation antidepressants (SGAs), light therapy, or psychotherapy. OBJECTIVES: To assess the efficacy and safety of second-generation antidepressants (SGAs) for the treatment of seasonal affective disorder (SAD) in adults in comparison with placebo, light therapy, other SGAs, or psychotherapy. SEARCH METHODS: This is an update of an earlier review first published in 2011...
March 4, 2021: Cochrane Database of Systematic Reviews
https://read.qxmd.com/read/33559153/population-based-signals-of-antidepressant-drug-interactions-associated-with-unintentional-traumatic-injury
#28
JOURNAL ARTICLE
Charles E Leonard, Colleen M Brensinger, Emily K Acton, Todd A Miano, Ghadeer K Dawwas, John R Horn, Sophie Chung, Warren B Bilker, Sascha Dublin, Samantha E Soprano, Thanh Phuong Pham Nguyen, Melanie M Manis, David W Oslin, Douglas J Wiebe, Sean Hennessy
Antidepressants are very widely used and associated with traumatic injury, yet little is known about their potential for harmful drug interactions. We aimed to identify potential drug interaction signals by assessing concomitant medications (precipitant drugs) taken with individual antidepressants (object drugs) that were associated with unintentional traumatic injury. We conducted pharmacoepidemiologic screening of 2000-2015 Optum Clinformatics data, identifying drug interaction signals by performing self-controlled case series studies for antidepressant + precipitant pairs and injury...
August 2021: Clinical Pharmacology and Therapeutics
https://read.qxmd.com/read/33398593/understanding-mechanisms-of-food-effect-and-developing-reliable-pbpk-models-using-a-middle-out-approach
#29
JOURNAL ARTICLE
Xavier J H Pepin, James E Huckle, Ravindra V Alluri, Sumit Basu, Stephanie Dodd, Neil Parrott, Arian Emami Riedmaier
Over the last 10 years, 40% of approved oral drugs exhibited a significant effect of food on their pharmacokinetics (PK) and currently the only method to characterize the effect of food on drug absorption, which is recognized by the authorities, is to conduct a clinical evaluation. Within the pharmaceutical industry, there is a significant effort to predict the mechanism and clinical relevance of a food effect. Physiologically based pharmacokinetic (PBPK) models combining both drug-specific and physiology-specific data have been used to predict the effect of food on absorption and to reveal the underlying mechanisms...
January 4, 2021: AAPS Journal
https://read.qxmd.com/read/33326436/exploring-the-utility-of-rdoc-in-differentiating-effectiveness-amongst-antidepressants-a-systematic-review-using-proposed-psychometrics-as-the-unit-of-analysis-for-the-negative-valence-systems-domain
#30
JOURNAL ARTICLE
Andrew Hui
BACKGROUND: RDoC conceptualises psychopathology as neurobiologically-rooted behavioural psychological "constructs" that span dimensionally from normality to pathology, but its clinical utility remains controversial. AIM: To explore RDoC's potential clinical utility by examining antidepressant effectiveness through Negative Valence Systems (NVS) domain constructs. METHOD: A systematic review was conducted on Web of Science, MEDLINE, EMBASE and PsycINFO for antidepressant trials that included psychometric instruments assessed by Watson, Stanton & Clark (2017) to represent NVS constructs of Acute Threat, Potential Threat and Loss...
2020: PloS One
https://read.qxmd.com/read/33194631/psychotropic-drugs-show-anticancer-activity-by-disrupting-mitochondrial-and-lysosomal-function
#31
JOURNAL ARTICLE
Marco Varalda, Annamaria Antona, Valentina Bettio, Konkonika Roy, Ajay Vachamaram, Vaibhav Yellenki, Alberto Massarotti, Gianluca Baldanzi, Daniela Capello
Background and Purpose: Drug repositioning is a promising strategy for discovering new therapeutic strategies for cancer therapy. We investigated psychotropic drugs for their antitumor activity because of several epidemiological studies reporting lower cancer incidence in individuals receiving long term drug treatment. Experimental Approach: We investigated 27 psychotropic drugs for their cytotoxic activity in colorectal carcinoma, glioblastoma and breast cancer cell lines. Consistent with the cationic amphiphilic structure of the most cytotoxic compounds, we investigated their effect on mitochondrial and lysosomal compartments...
2020: Frontiers in Oncology
https://read.qxmd.com/read/32848075/untargeted-metabolomics-reveals-anaerobic-glycolysis-as-a-novel-target-of-the-hepatotoxic-antidepressant-nefazodone
#32
JOURNAL ARTICLE
Evelin Krajnc, Michele Visentin, Zhibo Gai, Bruno Stieger, Sophia L Samodelov, Stephanie Häusler, Gerd A Kullak-Ublick
Mitochondrial damage is considered a hallmark of drug-induced liver injury (DILI). However, despite the common molecular etiology, the evolution of the injury is usually unpredictable, with some cases that are mild and reversible upon discontinuation of the treatment and others characterized by irreversible acute liver failure. This suggests that additional mechanisms of damage play a role in determining the progression of the initial insult. To uncover novel pathways potentially involved in DILI, we investigated in vitro the metabolic perturbations associated with nefazodone, an antidepressant associated with acute liver failure...
November 2020: Journal of Pharmacology and Experimental Therapeutics
https://read.qxmd.com/read/32788920/the-impact-of-antidepressants-on-depressive-symptom-severity-quality-of-life-morbidity-and-mortality-in-heart-failure-a-systematic-review
#33
JOURNAL ARTICLE
Rebecca Hedrick, Samuel Korouri, Emile Tadros, Tarneem Darwish, Veronica Cortez, Desiree Triay, Mia Pasini, Linda Olanisa, Nathalie Herrera, Sophia Hanna, Asher Kimchi, Michele Hamilton, Itai Danovitch, Waguih William IsHak
OBJECTIVE: The purpose of this paper is to review the literature on the impact of antidepressants on depressive symptom severity, quality of life (QoL), morbidity, and mortality in patients with heart failure (HF). METHODS: Following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) Reporting Items for Systematic Reviews and Meta-Analyses guidelines, studies published from December 1969 to December 2019 that pertain to depression and HF were identified through the use of the PubMed and PsycINFO databases, using the keywords: 'antidepressant*' and 'heart failure...
2020: Drugs in Context
https://read.qxmd.com/read/32563306/comparative-efficacy-and-acceptability-of-antidepressants-psychotherapies-and-their-combination-for-acute-treatment-of-children-and-adolescents-with-depressive-disorder-a-systematic-review-and-network-meta-analysis
#34
JOURNAL ARTICLE
Xinyu Zhou, Teng Teng, Yuqing Zhang, Cinzia Del Giovane, Toshi A Furukawa, John R Weisz, Xuemei Li, Pim Cuijpers, David Coghill, Yajie Xiang, Sarah E Hetrick, Stefan Leucht, Mengchang Qin, Jürgen Barth, Arun V Ravindran, Lining Yang, John Curry, Li Fan, Susan G Silva, Andrea Cipriani, Peng Xie
BACKGROUND: Depressive disorders are common in children and adolescents. Antidepressants, psychotherapies, and their combination are often used in routine clinical practice; however, available evidence on the comparative efficacy and safety of these interventions is inconclusive. Therefore, we sought to compare and rank all available treatment interventions for the acute treatment of depressive disorders in children and adolescents. METHODS: We did a systematic review and network meta-analysis...
July 2020: Lancet Psychiatry
https://read.qxmd.com/read/32285503/new-generation-non-ssri-antidepressants-drug-drug-interactions-and-therapeutic-drug-monitoring-part-2-nassas-nris-sndris-massas-ndris-and-others
#35
REVIEW
Michele Protti, Roberto Mandrioli, Camilla Marasca, Andrea Cavalli, Alessandro Serretti, Laura Mercolini
After the development of "classical" tricyclic antidepressants and monoamine oxidase inhibitors, numerous other classes of antidepressant drugs have been introduced onto the market. The selective serotonin reuptake inhibitor class is the best-known one, but many others exist, usually identified by their mechanism of activity. In this second part of the review, focused on new-generation antidepressants not included among selective serotonin reuptake inhibitors, the following classes are considered: noradrenergic and selective serotonergic antidepressants; norepinephrine reuptake inhibitors; serotonin, norepinephrine and dopamine reuptake inhibitors; melatonergic agonists and selective serotonergic antagonists; norepinephrine and dopamine reuptake inhibitors; and so forth...
September 2020: Medicinal Research Reviews
https://read.qxmd.com/read/32061744/therapeutic-drugs-modulate-atp-binding-cassette-transporter-mediated-transport-of-amyloid-beta-1-42-in-brain-microvascular-endothelial-cells
#36
JOURNAL ARTICLE
Maryam H Shubbar, Jeffrey I Penny
Deposition of amyloid-β peptide (Aβ(1-42) ) is a hallmark of Alzheimer's disease. Clearance of Aβ(1-42) , across the blood-brain barrier (BBB), is mediated by ATP-binding Cassette (ABC) efflux transporters. Many therapeutic drugs inhibit ABC transporters, but little is known of the effect of therapeutic drugs on Aβ(1-42) transport across BBB endothelial cells. The effects of selected, widely prescribed, therapeutic drugs on ABCB1, ABCC5 and ABCG2 activities were determined by measuring intracellular levels of calcein, GS-MF, and Hoechst 33342 respectively in primary porcine brain endothelial cells (PBECs)...
February 13, 2020: European Journal of Pharmacology
https://read.qxmd.com/read/31587356/clinically-relevant-drug-interactions-between-statins-and-antidepressants
#37
REVIEW
Caterina Palleria, Roberta Roberti, Luigi Francesco Iannone, Martina Tallarico, Maria Antonietta Barbieri, Ada Vero, Antonia Manti, Giovambattista De Sarro, Edoardo Spina, Emilio Russo
WHAT IS KNOWN AND OBJECTIVE: Statins, also known as 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, and antidepressant drugs are frequently used in combination due to the high and growing incidence of cardiovascular diseases and psychiatric disorders worldwide. Several aspects on management, the risk of adverse events (AEs) occurrence and the potential clinically relevant pharmacokinetic (PK) and pharmacodynamic (PD) drug-drug interactions (DDIs) between these two classes have not been well investigated...
April 2020: Journal of Clinical Pharmacy and Therapeutics
https://read.qxmd.com/read/31247926/indices-of-change-expectations-and-popularity-of-biological-treatments-for-major-depressive-disorder-between-1988-and-2017-a-scientometric-analysis
#38
JOURNAL ARTICLE
Bach X Tran, Giang H Ha, Giang T Vu, Long H Nguyen, Carl A Latkin, Kalpana Nathan, Roger S McIntyre, Cyrus S Ho, Wilson W Tam, Roger C Ho
BACKGROUND: Major Depressive Disorder (MDD) is the most common psychiatric disorder with high prevalence and disease burden. Biological treatments of MDD over the last several decades include a wide range of antidepressants and neurostimulation therapies. While recent meta-analyses have explored the efficacy and tolerability of antidepressants, the changing trends of biological treatments have not been evaluated. Our study measured the indices of change, expectations, and popularity of biological treatments of MDD between 1988 and 2017...
June 26, 2019: International Journal of Environmental Research and Public Health
https://read.qxmd.com/read/31110100/comparative-efficacy-and-acceptability-of-antidepressants-in-the-long-term-treatment-of-major-depression-protocol-for-a-systematic-review-and-networkmeta-analysis
#39
JOURNAL ARTICLE
Kiyomi Shinohara, Orestis Efthimiou, Edoardo G Ostinelli, Anneka Tomlinson, John R Geddes, Andrew A Nierenberg, Henricus G Ruhe, Toshi A Furukawa, Andrea Cipriani
INTRODUCTION: Pharmacotherapy plays an important role in the treatment of major depression. At the initiation of antidepressant treatment, both improvement of symptoms in the short term and relapse prevention in the long term should be taken into account. However, there is insufficient evidence regarding the efficacy and the acceptability of continuation/maintenance treatments and the relative efficacy/acceptability of antidepressants. OBJECTIVE: We will conduct a pairwise meta-analysis and a network meta-analysis (NMA) to examine the relative efficacy, tolerability and acceptability of antidepressants in the long-term treatment of major depression...
May 19, 2019: BMJ Open
https://read.qxmd.com/read/30996028/side-effect-profile-and-comparative-tolerability-of-21-antidepressants-in-the-acute-treatment-of-major-depression-in-adults-protocol-for-a-network-meta-analysis
#40
JOURNAL ARTICLE
Anneka Tomlinson, Orestis Efthimiou, Katharine Boaden, Emma New, Sarah Mather, Georgia Salanti, Hissei Imai, Yusuke Ogawa, Aran Tajika, Sanae Kishimoto, Sino Kikuchi, Astrid Chevance, Toshi A Furukawa, Andrea Cipriani
INTRODUCTION: We have recently compared all second-generation as well as selected first-generation antidepressants in terms of efficacy and acceptability in the acute treatment of major depression. Here we present a protocol for a network meta-analysis aimed at extending these results, updating the evidence base and comparing all second-generation as well as selected first-generation antidepressants in terms of specific adverse events and tolerability in the acute treatment of major depression in adults...
May 2019: Evidence-based Mental Health
keyword
keyword
161495
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.